Jeremy Ahouse, PhD — Executive Director Business Development and Global Alliances for Celgene. Jeremy is the alliance lead for a number of research and development alliances across Celgene’s portfolio. He joined Celgene in 2015 after alliance roles with Novartis, ImmunoGen, Vantage and Millennium. He started working in biotech and pharma in 1999 after completing a PhD in cellular immunology and a post-doc in developmental genetics. He has served ASAP as a board member and chair of the committee that prepares the CSAP and CAAM certification exams. He has a strong interest in multi-party agreements and in the ways that collaborations enhance scientific creativity.